Jonathan W. Goldman, Shun Lu, Jair Bar, Hidehito Horinouchi, Aaron Scott Mansfield, Christina S. Baik, John Stewart Hrom, Rebecca Heist, Christine Ratajczak, Shilpen Patel, Deise Uema, Summer Xia, Pallavi Mhaske, Mukesh Verma, David Ross Camidge. "LUMINOSITY, a phase 2 study of telisotuzumab vedotin in patients with c-Met protein–overexpressing non-squamous EGFR -wildtype advanced NSCLC: Efficacy outcomes by prior therapy.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8618